Clinical Trial

A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 2, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main purpose is to evaluate the accuracy of myocardial imaging obtained through integrated 18F-FDG PET/MR in detecting viable myocardium. The secondary objective is to evaluate whether myocardial imaging obtained through integrated 18F-FDG PET/MR can replace 18F-FDG PET combined with 99mTc MIBI SPECT/CT gated myocardial perfusion imaging.
Trial Details
NCT Number NCT06712862
Lead Sponsor Shanghai East Hospital
Conditions Ischemic Heart Disease
Enrollment 100 participants
Start Date 2025-12-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-02